CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 150 enrolled
Drug / intervention
Duloxetine +1 moredrug
Likely dose
Duloxetine 30 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04117893
NCT04117893Phase 4Completed

Duloxetine Combined With Intra-articular Injection of Corticosteroid and Hyaluronic Acid Reduces Pain in the Treatment of Knee Osteoarthritis Patients

Beijing Tiantan Hospital·interventional·Posted Oct 7, 2019·Updated Jul 11, 2023

In Brief

A Phase 4 clinical trial evaluating Duloxetine and intra-articular injection of corticosteroid and hyaluronic acid for Osteoarthritis, Knee and Chronic Pain. Completed, enrolled 150 participants across 1 site.

Detailed Summary

Intra-articular injection of corticosteroid and hyaluronic acid is a common treatment for osteoarthritis of the knee. As a treatment drug for patients with depression, duloxetine has been shown in many studies to effectively relieve the pain of osteoarthritis and improve the function of the knee joint. However, there is no evidence regarding the efficacy of Intra-articular injection of corticosteroid and hyaluronic acid combined with duloxetine for pain management in patients with knee osteoarthritis. The aim of the study was to test the hypothesis that Intra-articular injection of corticosteroid plus hyaluronic acid combined with duloxetine could achieve superior pain management effects to Intra-articular injection of corticosteroid plus hyaluronic acid alone in patients undergoing knee osteoarthritis pain.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesChina
Collaborators--

Timeline

Phase 4CompletedFinished
2020202120222023202420252026
First PostedOct 7, 2019
Enrollment StartOct 1, 2019
Primary CompletionJun 1, 2021
Study CompletionDec 31, 2021
TodayJul 1, 2026
Enrollment to primary: 1.7 yearsPosted 6.7 years ago

Interventions

Duloxetinedrug

Participants will start on duloxetine 30 mg per day for one week and then titrated up to duloxetine 60mg per day for 23 weeks.

intra-articular injection of corticosteroid and hyaluronic aciddrug

Participants will receive a 3.5 ml intra-articular injection of 30mg of hyaluronic acid plus 10mg of triamcinolone acetonide.